Menu
← Oncology Approval Tracker
FDA DECISION ·
Bendamustine Hydrochloride Injection (Baxter)
bendamustine hydrochloride · Baxter Healthcare
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Additional bendamustine injection for adults with CLL or indolent B-cell NHL that progressed during or within six months after rituximab-containing treatment.
LAMPGEN ANALYSIS
Why it matters
The FDA action authorizes another bendamustine presentation for the established oncology uses.
What research teams should watch
Check the presentation and product-specific preparation and confirm prior rituximab timing when applicable.
PRIMARY RECORDS